Calquence 00310-4513
Generic: Acalabrutinib
Product NDC
00310-4513- Manufacturer
- Astrazeneca Pharmaceuticals Lp
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- August 4, 2022
- Listing Expires
- December 31, 2027
- Application
- NDA216387
Need to source Calquence? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Acalabrutinib | 100 mg/1 |
Drug Class
Kinase Inhibitor [EPC]Kinase Inhibitor [EPC]Tyrosine Kinase Inhibitors [MoA]
Packaging Options(1)
60 TABLET, FILM COATED in 1 BOTTLE (0310-4513-60)